33rd Annual Pan Philadelphia Neurosurgery Conference - Virtual Meeting
This conference will explore past challenges and current controversies in cranial, vascular and spinal neurosurgery. Renowned guest speakers will join faculty from the three hosting institutions to discuss how new advances in these disciplines can significantly impact neurosurgical practice. Additionally, a resident research competition will highlight current research endeavors at the three sponsoring institutions.
- ICP Monitoring: Controversies and Current Status - Randall M Chesnut, MD, FCCM, FACS
- Management of Blunt Cerebrovascular Injuries (BCVI) - Arthur L. Day, MD
- Engineering the Future of Spinal Surgery - Nicholas Theodore, MD
This course is jointly provided by the Lewis Katz School of Medicine at Temple University, the Perelman School of Medicine at the University of Pennsylvania, and Sidney Kimmel Medical College at Thomas Jefferson University.
To successfully complete this activity, the required evaluation must be completed no later than Monday, January 17, 2022. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
It is designed for all specialists working in neurosurgery: practicing physicians, nurses, fellows and residents.
- Choose medical interventions and aggressive intervention for cerebrovascular injuries based on location.
- Make use of new advances in robotics, artificial intelligence and imaging in spine and spinal cord surgery.
- Utilize new protocols for the management of TBI patients with ICP and brain oxygen monitors.
- Model current patient strategies to align with updated practices in neurosurgery.
Any support received for this educational activity will be published and announced prior to the start of the activity.
Preliminary Program Agenda
This activity will be a virtual meeting. Instructions will be provided to you via email prior to the course.
|Randall M. Chesnut, MD|
UW School of Medicine
|Arthur L. Day, MD|
McGovern School of Medicine at UT Health
|Nicholas Theodore, MD, MS|
Johns Hopkins University School of Medicine
Conflict of Interest
Thomas Jefferson University endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any financial relationships with ACCME defined commercial interest entities within the past 24 months. Any conflict of interests have been mitigated prior to the educational activity.
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
Robert Rosenwasser, MD-Course Director
Michael Weaver, MD
Ali Ozturk, MD
Scott Shepard, MD
Rami Almefty, MD
Randall M Chesnut, MD, FCCM, FACS
Scott R. Shepard, MD
Philip A, Villanueva, MD
James M. Schuster, MD, PhD
Jack Jallo, MD, PhD
Arthur L. Day, MD
Nicholas Theodore, MD
Rami Almefty, MD
Bong-Soo Kim, MD
Joshua Heller, MD, PhD
Kadir Erkmen, MD
Pascual Jabbour, MD
Brian T. Jankowitz, MD
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, this activity has been planned and implemented by Thomas Jefferson University, Lewis Katz School of Medicine at Temple University, and the Perelman School of Medicine at the University of Pennsylvania. Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: This educational activity is designated for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals: This educational activity is designated for 4.0 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
- 4.00 AMA PRA Category 1 Credit™
- 4.00 Attendance
Virtual exhibit opportunities are available for this conference. For more information, please contact Bao Tram at email@example.com.
|Other Healthcare Professional||$50|
|Faculty, Staff & Residents from the Department of Neurosurgery at Temple, Penn & Jefferson||Complimentary|
|HOW TO REGISTER|
To register online, you must have a CPD @ JeffLearn account.
RECORDING AND PHOTOGRAPHY STRICTLY PROHIBITED
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.